Truist Securities Maintains Hold on Pediatrix Medical Group, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald maintains a Hold rating on Pediatrix Medical Group (NYSE:MD) and lowers the price target from $10 to $8.
July 15, 2024 | 2:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities has maintained a Hold rating on Pediatrix Medical Group and lowered the price target from $10 to $8.
The lowered price target from $10 to $8 by Truist Securities suggests a negative outlook on Pediatrix Medical Group's stock performance. This is likely to result in a short-term decline in the stock price as investors react to the reduced target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100